-
Published14/02/2025
-
Deadline21/03/2025
-
Opening of tenders21/03/2025
-
Awarded09/04/2025
-
Today24/08/2026
Utilities
- indicates CPV codes deduced from the text of the procedure
- indicates text translated automatically in your browsing language
Drug supply - Active substance okrrelizumab - ATC L04AG08
The subject of the contract is the continuous supply of a medicinal product containing the active substance okrrelizumab – ATC L04AG08. pharmaceutical form 300MG INF CNC SOL 1X10ML, unit of measurement 1X10ML, quantity 650 pharmaceutical form 920MG INJ SOL 1X23ML, unit of measurement 1X23ML, quantity 325
https://www.egordion.cz/nabidkaGORDION/profilTN
https://www.egordion.cz/nabidkaGORDION/profilTN
33652300 - Immunosuppressive agents
33660000 - Medicinal products for the nervous system and sensory organs
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.